Neurocrine Biosciences Executives Sell Shares
閱讀少於1分鐘
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Onyia Jude | Chief Scientific Officer | Sell | $7,803,687 | Form 4 |
| Delaet Ingrid | Chief Regulatory Officer | Sell | $61,695 | Form 4 |
Neurocrine Biosciences has seen recent share sales by two of its executives. Chief Scientific Officer, Jude Onyia, sold 59,819 shares of common stock on July 9, 2025, at a weighted average price of $130.455 per share, totaling $7,803,687. Following the transaction, Onyia directly owns 18,289 shares of the company.
Ingrid Delaet, Chief Regulatory Officer at Neurocrine Biosciences, sold 457 shares of Common Stock on July 10, 2025, at a price of $135.0 per share, totaling $61,695. Following this transaction, Delaet directly owns 4,730 shares of the company.